[Intramammary drug forms of neotil in treating mastitis during lactation].
Technological, biopharmaceutical, and clinico-pharmacological studies were carried out on the varying composition of drug formulas that included a tylosin base and neomycin sulfate, intended for the treatment of mastitis-affected cows during the lactation period. A base was developed of suitable viscosity and physico-chemical properties, that rapidly released the active ingredients included in it and made them penetrate in depth in the udder glandular tissue. Both the base and the drug formula Neotil were shown to be well tolerated. Following the single intracisternal infusion tylosin was excreted with the milk up to fifth milking (the 60th hour), and neomycin--up to the 4th milking (the 48th hour). When applied therapeutically in the case of clinical and subclinical mastitis Neotil led to the clinical and bacteriological recovery of 92.5 per cent of the affected quarters. Developed was a microbiological method for the analysis of the active ingredients contained in the drug formula and the milk secretion.
D000818:Animals; D002417:Cattle; D004338:Drug Combinations / Q000008:administration & dosage; D004341:Drug Evaluation / Q000662:veterinary; D005260:Female; D007774:Lactation / Q000187:drug effects*; D007933:Leucomycins / Q000008:administration & dosage*; D008038:Liniments; D008321:Mammary Glands, Animal; D008414:Mastitis, Bovine / Q000188:drug therapy*; D009355:Neomycin / Q000008:administration & dosage*; D011247:Pregnancy; D013997:Time Factors; D015645:Tylosin
D004338:Drug Combinations; D007933:Leucomycins; D008038:Liniments; C037038:neotil; D009355:Neomycin; D015645:Tylosin
Prouchvaniia vŭrkhu intramamarnata lekarstvena forma "neotil" za lekuvane na mastiti po vreme na laktatsiia.